Identifying and Developing
Breakthrough Medicines

Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. We leverage over 100 years of life science leadership to accelerate our clinical development program and are driven by the promise of developing life-changing oncology therapies on our path to become a leading biotech/pharmaceutical company.

Bexion Pharmaceuticals
Corporate Video

Bexion Milestones

Bexion Media

PRESS RELEASE

Bexion Pharmaceuticals, Inc. to Present at the 2021 Discovery on Target Conference
September 17, 2021

FOR IMMEDIATE RELEASE [Covington, KY—September 17, 2021] Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced today that Gilles Tapolsky PhD, MBA, Bexion’s Vice President, Pharmacology will be virtually presenting preclinical and clinical data of the Company’s lead compound, BXQ-350. The presentation will be made at the Discovery on Target (DOT) Conference in the Immunology and […]